Tekmira and Pfizer in research collaboration

Tekmira Pharmaceuticals (TSX:TKM) has initiated a new research collaboration with Pfizer to evaluate Tekmira’s stable nucleic acid-lipid particle (SNALP) technology to deliver small interfering RNA molecules provided by Pfizer (NYSE:PFE). This is Tekmira’s first formal research collaboration with Pfizer. Tekmira will be responsible for preparing the SNALP formulations and Pfizer will evaluate the formulations in [...]